Wuhan Keqian Biology (SHA:688526) said its porcine senecavirus A inactivated vaccine received official approval as a new veterinary drug from China's agriculture and rural affairs ministry.
Senecavirus A causes vesicular lesions in pigs that are hard to distinguish from diseases such as foot-and-mouth disease, according to a Tuesday filing with the Shanghai bourse.
The approval has a five-year monitoring period.
Shares of the veterinary drug manufacturer closed 1% higher Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments